Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 40 and 80 years old.
- People who meet the established medical diagnostic criteria for Parkinson's disease (based on Postuma et al., 2015 guidelines).
- People whose first movement-related symptom (such as stiffness, slowness, or tremor) began less than 36 months ago (for the Parkinson's disease group).
- People who meet the established medical diagnostic criteria for a condition called Progressive Supranuclear Palsy (based on Höglinger et al., 2017 guidelines).
- People whose first movement-related symptom (such as stiffness, slowness, or tremor), falls, or thinking and memory difficulties began less than 36 months ago (for the Progressive Supranuclear Palsy group).
- People who are covered by or registered with a social security or health insurance scheme.
- People who have read, understood, and signed the study consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a brain or nervous system condition other than the ones being studied in this trial, including a history of stroke, repeated head injuries, or a confirmed brain infection — if there is any doubt, the lead neurologist on the trial will decide.
- People who have certain metal objects or electronic devices in their body that make having an MRI scan unsafe, such as metal fragments in the eye, a heart pacemaker, a nerve or pain stimulator, cochlear (hearing) implants, a metal heart valve, or metal clips on a brain aneurysm.
- People who have claustrophobia (fear of enclosed spaces) or any other condition that would prevent them from having an MRI scan.
- People who score below 25 out of 30 on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA) — this applies to the Parkinson's disease group (confirm with trial site).
- People who are pregnant or breastfeeding.
- People who are under a legal protection order, such as guardianship or curatorship, or who are currently detained.
- People in the control (comparison) group who have a known history of any brain or nervous system condition, such as Parkinson's disease, Alzheimer's disease, stroke, brain tumour, multiple sclerosis, motor neurone disease, repeated head injuries, or confirmed brain infection — if there is any doubt, the lead neurologist on the trial will decide.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francois Cremieux, AP-HM
Phone: 0491385266
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Sodium accumulation between Parkinson disease patients and Progressive Supranuclear Palsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.